• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Noninvasive testing for chest pain may lead to increased invasive testing

byAnees DaudandJames Jiang
January 26, 2015
in Cardiology, Emergency
Reading Time: 3 mins read
β-blockers linked to improved survival in preserved ejection fraction heart failure
Share on FacebookShare on Twitter

1. Based on insurance claims data from emergency departments visits for chest pain, patients who did not undergo any testing for their complaint of chest pain had no more hospitalizations for myocardial infarctions compared to the patients who did undergo noninvasive cardiac testing.

2. However, those patients who underwent noninvasive testing were more likely to undergo cardiac catheterizations and revascularization procedures within a week after the initial visit, seemingly without benefit.

Evidence Rating Level: 2 (Good)       

Study Rundown: Emergency department visits related to chest pain are significant causes of health care expenditure, though mainly due to downstream spending. There are a number of different noninvasive tests that are utilized to risk stratify patients and determine who would most benefit from cardiac catheterization. This study sought to determine if there was an association between noninvasive cardiac testing versus no testing and the downstream effects for patients who presented to the ED with a complaint of chest pain. The results of the study suggested that patients who did not undergo any testing for their complaint of chest pain had no more hospitalizations for myocardial infarctions (MI) compared to the patients who did undergo noninvasive cardiac testing. However, those patients who underwent noninvasive testing were more likely to undergo cardiac catheterizations and revascularization procedures within a week after the initial visit, seemingly without benefit.

Strengths of the study include that all 50 states were represented, and a large sample size was included. However, since the rate of MIs was so low, it was difficult to identify significant differences amongst the different cohorts. Additionally, there were significant differences amongst patients how underwent testing compared to those who did, which adds significant bias to the data and makes it difficult to interpret (even though statistics were employed to account for this). Lastly, mortality data was not tracked in this study.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Duloxetine is effective in refractory chronic cough

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

Click to read an accompanying editorial in JAMA Internal Medicine

Relevant Reading: Coronary CT angiography versus standard evaluation in acute chest pain.

In-Depth [retrospective cohort]: The study cohort was gathered from MarketScan Commercial Claims and Encounters data from 2011, which consisted of private insurance claims from medium- and large-sized hospitals from across the US. In the final analysis, 421,774 patients with a primary or secondary complaint of chest pain in the ED were included, of which 293,788 did not receive a noninvasive cardiac test and 127,986 did undergo testing. The noninvasive testing strategies in the study were exercise electrocardiography (EE), stress echocardiography (SE), myocardial perfusion scintigraphy (MPS), and coronary computed tomography angiography (CCTA).

Between the two cohorts (tested vs non-tested), there was no significant difference in the number of hospitalizations for myocardial infarctions in the ensuing 7 or 180-days. There was also a higher likelihood of undergoing cardiac catheterization within 7 days, regardless of which noninvasive testing modality was utilized compared to no testing – EE OR 1.63, SE OR 1.10, MPS OR 2.48, and CCTA OR 1.91. This was also true of coronary interventions for those who underwent testing compared to those who did not.

More from this author: Withholding and withdrawing care viewed as different among Asian intensivists, Whole grain consumption associated with decreased all-cause, cardiovascular mortality, Cardiac mortality paradoxically lower during times of national cardiology conferences, Active smoking cessation intervention may provide tangible results [Project CLIQ], Reperfusion therapy may be suboptimal for STEMIs requiring transfers

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: chest painmyocardial infarction
Previous Post

Prochlorperazine for migraine may lower likelihood of ED return

Next Post

Early removal from neglect may promote normal white matter development

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Chronic Disease

Duloxetine is effective in refractory chronic cough

January 21, 2026
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

October 30, 2025
Next Post
Early removal from neglect may promote normal white matter development

Early removal from neglect may promote normal white matter development

Radiation from follow-up imaging may significantly impact life expectancy

Radiation from follow-up imaging may significantly impact life expectancy

RAS mutation linked with survival in metastatic colorectal cancer

Radiofrequency ablation of lung metastases may prolong survival

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.